Back to MORGAN STANLEY MORGAN STANLEY

ALLOALLO
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ALLOGENE THERAPEUTICS INC

MORGAN STANLEY holds 4.5M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $9.4M as of 2026-Q2. The position was increased (+351.5% shares). ALLO represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$9.4M

Current Shares

4.5M

Total Value Change

+$4.4M

Total Shares Change

+2.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.5M
+351.5%
$9.4M0.0%$2.08
45
2026-Q1
Increased
998,845
+42.1%
$2.4M0.0%$2.53
35
2025-Q4
Decreased
703,138
-45.9%
$963,2980.0%$1.31
0
2025-Q3
Increased
1.3M
+113.3%
$1.6M0.0%$1.27
41
2025-Q2
Decreased
608,969
-74.1%
$688,1360.0%$1.18
0
2025-Q1
Increased
2.4M
+135.6%
$3.4M0.0%$1.55
43
2024-Q4
Decreased
998,596
-42.0%
$2.1M0.0%$2.10
0
2024-Q3
Decreased
1.7M
-20.2%
$4.8M0.0%$2.91
0
2024-Q2
New
2.2M
-
$5M0.0%$2.33
37

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used